Brachytherapy for Rectal Cancer

Rectal cancer surgery is complicated by the proximity of the rectum to other organs and structures. Patients often have to make the difficult choice between radical resection, which requires subsequent use of a stoma, or sphincter preservation surgery that maintains quality of life but carries a higher risk of recurrence. Brachytherapy for rectal cancer is now available as a potential alternative to surgery for patients with low-lying small rectal tumors.

Read more

Treatments for Non-Melanoma Skin Cancer

Non-melanoma skin cancer is a term used for all the cancer types that happen in the skin but are not melanoma. This includes several types of skin cancer including squamous cell skin cancers and basal cell carcinoma. In this article, we discuss some of the key non-melanoma skin cancer treatments and their key characteristics. 

Read more

Alternative Breast Cancer Treatments – What Works?

Receiving a breast cancer diagnosis can be extremely worrying and intimidating for patients. Very few of us are well informed regarding the different treatment options available for breast cancer, and as such we may not be aware of some of the alternative breast cancer treatments available.

Knowledge is power and making informed choices under the guidance of a doctor regarding the treatment route you choose is important. This article aims to explain some of the alternative breast cancer treatments available and which of them actually work.

Read more

Rectal Cancer Treatments, by Stage

Rectal cancer is a type of cancer in which malignant cancer cells form in the tissues of the rectum. There is a range of rectal cancer treatments that can be carried out, varying concerning the cancer stage. This article will discuss the key stages of the disease and which rectal cancer treatments should be offered accordingly.

Read more

Improving Patient-Centered X-ray Brachytherapy Treatment with Papillon+™

A 2020 report from The International Agency for Research on Cancer (IARC) estimated that as many as 1 in 5 people globally would experience a form of cancer during their lifetime.

Global aging populations and a range of socio-economic risk factors represent some of the key drivers of this increase. There is an ever-increasing demand for cost-effective, accessible, efficient, and patient-centered cancer therapy and treatment.

Ariane’s Papillon+™ system offers medical practitioners a turnkey solution to successful rectal, superficial and intraoperative X-ray brachytherapy via a range of treatment modalities.

Read more

2019 Biotechnology Awards – WINNER

GHP Announces the 2019 Biotechnology Awards Winners

GHP Magazine has announced the winners of the 2019 Biotechnology Awards.

Most Innovative Cancer Treatment Manufacturer – Midlands

Ariane Medical Systems Ltd was delighted to be announced winners of the Most Innovative Cancer Treatment Manufacturer – Midlands regional category. Following on from our Medilink Innovation Award in June 2018 this award further shows how Papillon Brachytherapy Systems have brought new life to an old cancer treatment technique.

Read more

Ariane Macmillan Coffee Morning

Ariane Macmillan Coffee Morning – 28th September 2018 10am to 12 noon.

Join Ariane Medical Systems as we host our Macmillan Coffee Morning on 28th September 2018.

Our coffee morning will take place between 10 am and 12 noon at Ariane Medical Systems Ltd, 151 Mansfield Road, Alfreton, DE55 7JQ.

Read more

Clatterbridge Cancer Centre win BMJ Award for Rectal Cancer Care

Clatterbridge Cancer Center win Prestigious UK Cancer Care Award

Introduction

A coveted British Medical Journal award was recently bestowed on the Papillon team at The Clatterbridge Cancer Center. The Cancer Care Team category was won by the entry—Papillon for Rectal Cancer.

This life-changing treatment was pioneered by The Clatterbridge Cancer Center when Lead Papillon Clinician Professor Arthur Sun Myint initially introduced the method to the United Kingdom, more than two decades ago. He stated that the honour was the reward for the team’s hard work and their philosophy of always putting patients’ interest first.

Read more

Papillon+ receives Medilink Innovation Award

Medilink Innovation Award – Innovative Cancer Care

The award from Medilink East Midlands recognises our Papillon+ device. For its contribution to improving outcomes for rectal cancer patients.

Because Papillon+ treatments can be completed on an outpatient basis, the Papillon+ x-ray brachytherapy system can reduce treatment times. As well as preventing the need for radical surgery, which often results in a Stoma.

Read more

Papillon Patients in Phase III Opera Trial

The Phase III trial called OPERA which started in France at the end of 2015 has now passed Ethics here in the UK.

Read more